Financials
- Market Capitalization 439.86 M
- Employee 40
- Founded 2022
- CEO N/A
- Website www.zurabio.com
- Headquarter Cayman Islands
- FIGI UNKNOWN
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-4.94
ratio cours/chiffre d'affaires
100.37
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 2907 | YDES YD Bio Limited - Ordinary Shares | 6.35 USD | +4.10% | +5.13% | +67.55% | -65.68% | 449.51 M USD | ||
| 2913 | NGNE Neurogene Inc. - Common Stock | 22.02 USD | +2.13% | -14.32% | -37.16% | -25.15% | 440.65 M USD | ||
| 2924 | ENTX Entera Bio Ltd. - Ordinary Shares | 2.50 USD | +0.40% | -2.72% | -9.75% | +1.63% | 432.85 M USD | ||
| 2934 | AUTL Autolus Therapeutics plc - American Depositary Shares | 1.64 USD | +1.23% | -8.89% | -15.90% | -1.20% | 436.51 M USD |